Clinical Trial Update: Integrated Dose Escalation for Advanced, Localized Gynecologic Cancer (The IDEAL - GYN Trial) [NA]

View source ↗

Summary

A completed IDEAL-GYN trial reported dose escalation for advanced and localized gynecologic cancer (cervical cancer).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Cancer
• Cervical Neoplasms

Snippet

Sponsor: Duke University | Conditions: Cancer of the Cervix, Cervical Neoplasms | NA | Status: COMPLETED | Results posted: 2020-03-10